medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2013, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2013; 58 (2)

Pericarditis at the ABC Medical Center

López VPT, Halabe CJ, López VBP

Language: Spanish
References: 32
Page: 95-100
PDF size: 67.49 Kb.


ABSTRACT

Background: Pericarditis is a disease caused by inflammation of the pericardium secondary to multiple etiologies. Objective: To know the incidence of pericarditis in our institution, main etiologic causes, diagnostic and treatment. Secondary end point, to prove combined therapy is not superior to monotherapy in the treatment of idiopathic cases. Material and methods: Retrospective study, between 2000 and 2010, files of patients with diagnosis of pericarditis of any etiology were reviewed. Due to the fact that idiopathic pericarditis comprises the major group, it was divided into two: the first one including all patients who only received non steroidal anti-inflamatories as monotherapy and the second one, with all those patients with idiopathic pericarditis of any etiology with combined therapy observing differences as for days of hospitalization and number of recurrences in both groups. The statistical analysis was realized by means of t student test. Results: Of 213 brought patients, only 120 expired with diagnostic criteria by what the rest was excluded from the study. The incidence of pericarditis was 2% without statistically significant differences in gender and age. The thoracic pain was the predominant symptom. The average time in days from the diagnosis up to the beginning of treatment was 6.5 days. Twenty five percent presented at least a recurrence. Between patients with recurrent pericarditis of any etiology, 43.7 % received anti-inflammatory monotherapy, the rest of them received combined therapy (steroids and aspirin). The idiopathic pericarditis was the most frequent (62 %), followed by the traumatic one (11%). There was verified in our study that in the treatment of recurrent idiopathic pericarditis, the combined therapy is not superior to the monotherapy since we do not observe a statistically significant reduction in the days of hospitalization or recurrences. Conclusion: Pericarditis is a frequent pathology with an incidence of 2% in the ABC Medical Center.


REFERENCES

  1. Osler W. Chronic cyanosis, with polycythaemia and enlarged spleen: a new clinical entity. Am J Med Sci. 2008; 335: 411-417.

  2. Knowlton KU. Myocarditis and Pericarditis. In: Knowlton KU, Savoia MC, Oxman MN. Mandell’s Principles and Practice of Infectious Diseases. Philadelphia: Elsevier; 2009. p. 1161- 1171.

  3. Rábago J, Nellen H, Halabe JH. Pericarditis recidivante y fiebre mediterránea familiar. Rev Med Inst Mex Seguro Soc. 2009; 47 (2): 211-214.

  4. Lorell BH. Pericardial diseases. In: Braunwald E. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: W.B. Saunders; 1997. p. 1478-1534.

  5. Launbjerg J, Fruergaard P, Hesse B, Jorgensen F, Elsborg L, Petri A. Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology. 1996; 87: 60-66.

  6. Zayas R, Anguita M, Torres F et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995; 75: 378-382.

  7. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985; 56: 623-630.

  8. Imazio M, Demichelis B, Cecchi E et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003; 42: 2144-2148.

  9. Bonnefoy E, Godon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J. 2000; 21: 832-836.

  10. Allaria A, Michelli D, Capelli H, Berri G, Gutierrez D. Transient cardiac constriction following purulent pericarditis. Eur J Pediatr. 1992; 151: 250-251.

  11. Oh JK, Hatle LK, Mulvagh SL, Tajik AJ. Transient constrictive pericarditis: diagnosis by two-dimensional Doppler echocardiography. Mayo Clin Proc. 1993; 68: 1158-1164.

  12. Woods T, Vidarsson B, Mosher D, Stein JH. Transient effusive-constrictive pericarditis due to chemotherapy. Clin Cardiol. 1999; 22: 316-318.

  13. Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987; 59: 961-966.

  14. Imazio M, Spodick D, Brucato A et al. Controversial Issues in the management of pericardial diseases. Circulation. 2010; 121: 916-928.

  15. Levine B, Bradley AL. Metabolic syndrome and cardiovascular disease. Pericarditis, Pericardial constriction and pericardial tamponade. 2006; 53: 341-347.

  16. Vargas AC et al. Pericarditis purulenta: presentación de un caso y diagnósticos diferenciales. Arch Cardiol Mex. 2006; 76 (1): 83-89.

  17. Lange RA, Hills DL. Acute Pericartidis. N Engl J Med. 2004; 351 (21): 2145-2202.

  18. Schwefer M et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur J Cardiothorac Surg. 2009; 36: 502-510.

  19. Sheth et al. Current and emerging strategies for the treatment of acute pericarditis: a systematic review. J Inflamm Res. 2010; 3: 135-142.

  20. Gouny P et al. Pericardial effusion and AIDS: benefits of surgical drainage. Eur J Cardiothorac Surg. 1998; 13: 165-169.

  21. Aguilar JA et al. Pericarditis tuberculosa. Experiencia de 10 ańos. Arch Cardiol Mex. 2007; 77: 209-216.

  22. Olsen PS et al. Surgical treatment of large pericardial effusions: etiology and long-term survival. Eur J Cardio-thorac Surg. 1991; 5: 430-432.

  23. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart. 2004; 90: 1364-1368.

  24. Imazio M, Demichelis B, Parrini I, Cecchi E, Demarie D, Ghisio A, Belli R, Bobbio M, Trinchero R. Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol. 2005; 96: 736-739.

  25. Shabetai R. Recurrent pericarditis. Recent advances and remaining questions. Circulation. 2005; 112: 1921-1923.

  26. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005; 112: 2012-2016.

  27. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M et al. Colchicine as first choice therapy for recurrent pericarditis. Arch Intern Med. 2005; 165: 1987-1991.

  28. Maisch B, Ristic A, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J. 2002; 23: 1503-1508.

  29. Friedman PL, Brown EJ Jr, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med. 1981; 305: 1171-1175.

  30. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002; 360: 1071-1073.

  31. Adler Y, Finkelstein Y, Guindo J, Rodríguez de la Serna A, Shoenfeld Y, Bayes-Genis A, Sagie A, Bayes de Luna A, Spodick DH. Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation. 1998; 97: 2183-2185.

  32. Artom G, Koren-Morag N, Spodick DH, Brucato A, Guindo J, Bayes de Luna A, Brambilla G et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multicentre all-case analysis. Eur Heart J. 2005; 26: 723-727.




2020     |     www.medigraphic.com